nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP11A1—Dexamethasone—hematologic cancer	0.0288	0.0451	CbGbCtD
Terbinafine—CYP1A2—Anagrelide—hematologic cancer	0.0254	0.0397	CbGbCtD
Terbinafine—PTGS1—Bortezomib—hematologic cancer	0.0241	0.0378	CbGbCtD
Terbinafine—CYP19A1—Betamethasone—hematologic cancer	0.0231	0.0361	CbGbCtD
Terbinafine—PTGS1—Thalidomide—hematologic cancer	0.021	0.0329	CbGbCtD
Terbinafine—PTGS1—Ifosfamide—hematologic cancer	0.0185	0.029	CbGbCtD
Terbinafine—PTGS1—Imatinib—hematologic cancer	0.0177	0.0277	CbGbCtD
Terbinafine—CYP11A1—ovarian follicle—hematologic cancer	0.0172	0.289	CbGeAlD
Terbinafine—CYP2C9—Bexarotene—hematologic cancer	0.0158	0.0248	CbGbCtD
Terbinafine—CYP2C8—Bortezomib—hematologic cancer	0.0139	0.0218	CbGbCtD
Terbinafine—CYP2D6—Lomustine—hematologic cancer	0.0135	0.0211	CbGbCtD
Terbinafine—CYP19A1—Dexamethasone—hematologic cancer	0.0134	0.021	CbGbCtD
Terbinafine—CYP1A2—Carmustine—hematologic cancer	0.0133	0.0209	CbGbCtD
Terbinafine—CYP2C9—Idarubicin—hematologic cancer	0.0131	0.0205	CbGbCtD
Terbinafine—CYP2D6—Idarubicin—hematologic cancer	0.012	0.0188	CbGbCtD
Terbinafine—CYP2C19—Bortezomib—hematologic cancer	0.0117	0.0183	CbGbCtD
Terbinafine—CYP1A2—Methoxsalen—hematologic cancer	0.0113	0.0177	CbGbCtD
Terbinafine—CYP19A1—ovarian follicle—hematologic cancer	0.0112	0.188	CbGeAlD
Terbinafine—CYP1A2—Bortezomib—hematologic cancer	0.0108	0.0169	CbGbCtD
Terbinafine—CYP2C8—Ifosfamide—hematologic cancer	0.0107	0.0167	CbGbCtD
Terbinafine—CYP1A2—Daunorubicin—hematologic cancer	0.0103	0.0161	CbGbCtD
Terbinafine—CYP2D6—Hydroxyurea—hematologic cancer	0.0102	0.016	CbGbCtD
Terbinafine—CYP2C19—Thalidomide—hematologic cancer	0.0102	0.0159	CbGbCtD
Terbinafine—CYP1A2—Alitretinoin—hematologic cancer	0.0101	0.0158	CbGbCtD
Terbinafine—CYP2C9—Bortezomib—hematologic cancer	0.00971	0.0152	CbGbCtD
Terbinafine—CYP2C19—Teniposide—hematologic cancer	0.0097	0.0152	CbGbCtD
Terbinafine—CYP1A2—Thalidomide—hematologic cancer	0.00939	0.0147	CbGbCtD
Terbinafine—CYP2C8—Nilotinib—hematologic cancer	0.00927	0.0145	CbGbCtD
Terbinafine—CYP3A4—Bexarotene—hematologic cancer	0.00921	0.0144	CbGbCtD
Terbinafine—CYP2C19—Ifosfamide—hematologic cancer	0.00896	0.014	CbGbCtD
Terbinafine—CYP2D6—Bortezomib—hematologic cancer	0.00888	0.0139	CbGbCtD
Terbinafine—PTGS1—Etoposide—hematologic cancer	0.00884	0.0138	CbGbCtD
Terbinafine—CYP3A4—Lomustine—hematologic cancer	0.00856	0.0134	CbGbCtD
Terbinafine—CYP3A4—Busulfan—hematologic cancer	0.00856	0.0134	CbGbCtD
Terbinafine—CYP2C19—Imatinib—hematologic cancer	0.00856	0.0134	CbGbCtD
Terbinafine—CYP2C9—Thalidomide—hematologic cancer	0.00846	0.0132	CbGbCtD
Terbinafine—CYP1A2—Dacarbazine—hematologic cancer	0.00807	0.0126	CbGbCtD
Terbinafine—CYP2C9—Teniposide—hematologic cancer	0.00807	0.0126	CbGbCtD
Terbinafine—CYP1A2—Imatinib—hematologic cancer	0.00789	0.0124	CbGbCtD
Terbinafine—CYP3A4—Thiotepa—hematologic cancer	0.00763	0.0119	CbGbCtD
Terbinafine—CYP2C9—Ifosfamide—hematologic cancer	0.00745	0.0117	CbGbCtD
Terbinafine—CYP2C9—Imatinib—hematologic cancer	0.00711	0.0111	CbGbCtD
Terbinafine—CYP2D6—Imatinib—hematologic cancer	0.0065	0.0102	CbGbCtD
Terbinafine—CYP2C9—Nilotinib—hematologic cancer	0.00646	0.0101	CbGbCtD
Terbinafine—CYP1A2—Dasatinib—hematologic cancer	0.00634	0.00993	CbGbCtD
Terbinafine—CYP3A4—Methoxsalen—hematologic cancer	0.00593	0.00929	CbGbCtD
Terbinafine—CYP2D6—Nilotinib—hematologic cancer	0.00591	0.00925	CbGbCtD
Terbinafine—CYP2D6—Vinorelbine—hematologic cancer	0.00586	0.00918	CbGbCtD
Terbinafine—CYP3A4—Bortezomib—hematologic cancer	0.00564	0.00884	CbGbCtD
Terbinafine—CYP2C19—Prednisone—hematologic cancer	0.00564	0.00882	CbGbCtD
Terbinafine—CYP3A4—Daunorubicin—hematologic cancer	0.0054	0.00845	CbGbCtD
Terbinafine—CYP2C8—Etoposide—hematologic cancer	0.0051	0.00799	CbGbCtD
Terbinafine—CYP3A4—Cytarabine—hematologic cancer	0.00476	0.00746	CbGbCtD
Terbinafine—CYP3A4—Teniposide—hematologic cancer	0.00469	0.00734	CbGbCtD
Terbinafine—CYP3A4—Ifosfamide—hematologic cancer	0.00433	0.00678	CbGbCtD
Terbinafine—CYP2C8—Dexamethasone—hematologic cancer	0.00419	0.00657	CbGbCtD
Terbinafine—CYP3A4—Imatinib—hematologic cancer	0.00414	0.00647	CbGbCtD
Terbinafine—CYP1A2—Etoposide—hematologic cancer	0.00395	0.00618	CbGbCtD
Terbinafine—CYP3A4—Ruxolitinib—hematologic cancer	0.00389	0.0061	CbGbCtD
Terbinafine—CYP3A4—Nilotinib—hematologic cancer	0.00376	0.00588	CbGbCtD
Terbinafine—CYP3A4—Vinorelbine—hematologic cancer	0.00373	0.00583	CbGbCtD
Terbinafine—CYP2C9—Cisplatin—hematologic cancer	0.00362	0.00567	CbGbCtD
Terbinafine—CYP2D6—Vinblastine—hematologic cancer	0.00361	0.00565	CbGbCtD
Terbinafine—CYP2C19—Dexamethasone—hematologic cancer	0.00352	0.00551	CbGbCtD
Terbinafine—CYP3A4—Triamcinolone—hematologic cancer	0.00341	0.00534	CbGbCtD
Terbinafine—CYP3A4—Dasatinib—hematologic cancer	0.00332	0.0052	CbGbCtD
Terbinafine—CYP3A4—Mitoxantrone—hematologic cancer	0.00328	0.00514	CbGbCtD
Terbinafine—CYP2C9—Dexamethasone—hematologic cancer	0.00293	0.00458	CbGbCtD
Terbinafine—CYP3A4—Betamethasone—hematologic cancer	0.00292	0.00458	CbGbCtD
Terbinafine—CYP3A4—Prednisolone—hematologic cancer	0.00289	0.00452	CbGbCtD
Terbinafine—CYP3A4—Prednisone—hematologic cancer	0.00272	0.00427	CbGbCtD
Terbinafine—CYP2D6—Dexamethasone—hematologic cancer	0.00268	0.00419	CbGbCtD
Terbinafine—CYP3A4—Irinotecan—hematologic cancer	0.00258	0.00404	CbGbCtD
Terbinafine—SQLE—gonad—hematologic cancer	0.00241	0.0404	CbGeAlD
Terbinafine—CYP3A4—Vinblastine—hematologic cancer	0.0023	0.0036	CbGbCtD
Terbinafine—CYP3A4—Vincristine—hematologic cancer	0.00226	0.00353	CbGbCtD
Terbinafine—CYP2D6—Doxorubicin—hematologic cancer	0.00222	0.00347	CbGbCtD
Terbinafine—CYP11A1—hematopoietic system—hematologic cancer	0.00207	0.0348	CbGeAlD
Terbinafine—CYP3A4—Etoposide—hematologic cancer	0.00207	0.00324	CbGbCtD
Terbinafine—SQLE—lung—hematologic cancer	0.00184	0.0309	CbGeAlD
Terbinafine—SQLE—testis—hematologic cancer	0.00173	0.0291	CbGeAlD
Terbinafine—CYP3A4—Dexamethasone—hematologic cancer	0.0017	0.00266	CbGbCtD
Terbinafine—CYP11A1—gonad—hematologic cancer	0.00158	0.0265	CbGeAlD
Terbinafine—CYP3A4—Doxorubicin—hematologic cancer	0.00141	0.00221	CbGbCtD
Terbinafine—CYP11A1—blood—hematologic cancer	0.00137	0.0231	CbGeAlD
Terbinafine—CYP19A1—hematopoietic system—hematologic cancer	0.00135	0.0226	CbGeAlD
Terbinafine—SQLE—lymph node—hematologic cancer	0.00126	0.0211	CbGeAlD
Terbinafine—CYP11A1—testis—hematologic cancer	0.00114	0.0191	CbGeAlD
Terbinafine—CYP2C19—hematopoietic system—hematologic cancer	0.00111	0.0186	CbGeAlD
Terbinafine—CYP19A1—gonad—hematologic cancer	0.00102	0.0172	CbGeAlD
Terbinafine—CYP2C8—hematopoietic system—hematologic cancer	0.000965	0.0162	CbGeAlD
Terbinafine—CYP1A2—hematopoietic system—hematologic cancer	0.000903	0.0152	CbGeAlD
Terbinafine—CYP19A1—blood—hematologic cancer	0.000893	0.015	CbGeAlD
Terbinafine—CYP2C9—hematopoietic system—hematologic cancer	0.000857	0.0144	CbGeAlD
Terbinafine—CYP11A1—lymph node—hematologic cancer	0.000824	0.0138	CbGeAlD
Terbinafine—PTGS1—hematopoietic system—hematologic cancer	0.000782	0.0131	CbGeAlD
Terbinafine—CYP19A1—testis—hematologic cancer	0.000738	0.0124	CbGeAlD
Terbinafine—CYP2C19—blood—hematologic cancer	0.000732	0.0123	CbGeAlD
Terbinafine—CYP3A4—hematopoietic system—hematologic cancer	0.000653	0.011	CbGeAlD
Terbinafine—CYP2D6—hematopoietic system—hematologic cancer	0.000643	0.0108	CbGeAlD
Terbinafine—CYP2C8—blood—hematologic cancer	0.000639	0.0107	CbGeAlD
Terbinafine—CYP1A2—blood—hematologic cancer	0.000598	0.01	CbGeAlD
Terbinafine—CYP2C9—blood—hematologic cancer	0.000568	0.00954	CbGeAlD
Terbinafine—CYP19A1—lymph node—hematologic cancer	0.000535	0.00899	CbGeAlD
Terbinafine—CYP2C8—testis—hematologic cancer	0.000529	0.00888	CbGeAlD
Terbinafine—CYP1A2—lung—hematologic cancer	0.000524	0.00881	CbGeAlD
Terbinafine—PTGS1—blood—hematologic cancer	0.000518	0.00871	CbGeAlD
Terbinafine—PTGS1—lung—hematologic cancer	0.000454	0.00763	CbGeAlD
Terbinafine—CYP3A4—blood—hematologic cancer	0.000433	0.00727	CbGeAlD
Terbinafine—PTGS1—testis—hematologic cancer	0.000429	0.0072	CbGeAlD
Terbinafine—CYP2D6—blood—hematologic cancer	0.000426	0.00716	CbGeAlD
Terbinafine—CYP2D6—testis—hematologic cancer	0.000352	0.00592	CbGeAlD
Terbinafine—PTGS1—lymph node—hematologic cancer	0.000311	0.00522	CbGeAlD
Terbinafine—Eye disorder—Epirubicin—hematologic cancer	3.09e-05	0.000127	CcSEcCtD
Terbinafine—Hypersensitivity—Etoposide—hematologic cancer	3.09e-05	0.000126	CcSEcCtD
Terbinafine—Tinnitus—Epirubicin—hematologic cancer	3.08e-05	0.000126	CcSEcCtD
Terbinafine—Erythema—Methotrexate—hematologic cancer	3.07e-05	0.000126	CcSEcCtD
Terbinafine—Headache—Gemcitabine—hematologic cancer	3.07e-05	0.000126	CcSEcCtD
Terbinafine—Nausea—Vincristine—hematologic cancer	3.07e-05	0.000126	CcSEcCtD
Terbinafine—Hepatitis—Doxorubicin—hematologic cancer	3.06e-05	0.000125	CcSEcCtD
Terbinafine—Hypersensitivity—Prednisolone—hematologic cancer	3.04e-05	0.000125	CcSEcCtD
Terbinafine—Hypoaesthesia—Doxorubicin—hematologic cancer	3.04e-05	0.000125	CcSEcCtD
Terbinafine—Dyspepsia—Betamethasone—hematologic cancer	3.04e-05	0.000124	CcSEcCtD
Terbinafine—Dyspepsia—Dexamethasone—hematologic cancer	3.04e-05	0.000124	CcSEcCtD
Terbinafine—Urticaria—Triamcinolone—hematologic cancer	3.02e-05	0.000124	CcSEcCtD
Terbinafine—Dysgeusia—Methotrexate—hematologic cancer	3.01e-05	0.000123	CcSEcCtD
Terbinafine—Asthenia—Etoposide—hematologic cancer	3.01e-05	0.000123	CcSEcCtD
Terbinafine—Connective tissue disorder—Doxorubicin—hematologic cancer	3.01e-05	0.000123	CcSEcCtD
Terbinafine—Body temperature increased—Triamcinolone—hematologic cancer	3e-05	0.000123	CcSEcCtD
Terbinafine—Anaphylactic shock—Prednisone—hematologic cancer	3e-05	0.000123	CcSEcCtD
Terbinafine—Angiopathy—Epirubicin—hematologic cancer	3e-05	0.000123	CcSEcCtD
Terbinafine—Decreased appetite—Betamethasone—hematologic cancer	3e-05	0.000123	CcSEcCtD
Terbinafine—Decreased appetite—Dexamethasone—hematologic cancer	3e-05	0.000123	CcSEcCtD
Terbinafine—Nausea—Mitoxantrone—hematologic cancer	2.99e-05	0.000123	CcSEcCtD
Terbinafine—Nausea—Irinotecan—hematologic cancer	2.99e-05	0.000123	CcSEcCtD
Terbinafine—Immune system disorder—Epirubicin—hematologic cancer	2.99e-05	0.000122	CcSEcCtD
Terbinafine—Infection—Prednisone—hematologic cancer	2.98e-05	0.000122	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.98e-05	0.000122	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.98e-05	0.000122	CcSEcCtD
Terbinafine—Fatigue—Dexamethasone—hematologic cancer	2.97e-05	0.000122	CcSEcCtD
Terbinafine—Fatigue—Betamethasone—hematologic cancer	2.97e-05	0.000122	CcSEcCtD
Terbinafine—Pruritus—Etoposide—hematologic cancer	2.96e-05	0.000121	CcSEcCtD
Terbinafine—Pain—Betamethasone—hematologic cancer	2.95e-05	0.000121	CcSEcCtD
Terbinafine—Pain—Dexamethasone—hematologic cancer	2.95e-05	0.000121	CcSEcCtD
Terbinafine—Visual impairment—Doxorubicin—hematologic cancer	2.95e-05	0.000121	CcSEcCtD
Terbinafine—Nervous system disorder—Prednisone—hematologic cancer	2.94e-05	0.000121	CcSEcCtD
Terbinafine—Alopecia—Epirubicin—hematologic cancer	2.92e-05	0.00012	CcSEcCtD
Terbinafine—Skin disorder—Prednisone—hematologic cancer	2.92e-05	0.000119	CcSEcCtD
Terbinafine—Nausea—Gemcitabine—hematologic cancer	2.91e-05	0.000119	CcSEcCtD
Terbinafine—Vomiting—Cisplatin—hematologic cancer	2.91e-05	0.000119	CcSEcCtD
Terbinafine—Vision blurred—Methotrexate—hematologic cancer	2.9e-05	0.000119	CcSEcCtD
Terbinafine—Mental disorder—Epirubicin—hematologic cancer	2.9e-05	0.000119	CcSEcCtD
Terbinafine—Erythema multiforme—Doxorubicin—hematologic cancer	2.89e-05	0.000118	CcSEcCtD
Terbinafine—Rash—Cisplatin—hematologic cancer	2.88e-05	0.000118	CcSEcCtD
Terbinafine—Dermatitis—Cisplatin—hematologic cancer	2.88e-05	0.000118	CcSEcCtD
Terbinafine—Erythema—Epirubicin—hematologic cancer	2.88e-05	0.000118	CcSEcCtD
Terbinafine—Diarrhoea—Etoposide—hematologic cancer	2.87e-05	0.000117	CcSEcCtD
Terbinafine—Anorexia—Prednisone—hematologic cancer	2.86e-05	0.000117	CcSEcCtD
Terbinafine—Eye disorder—Doxorubicin—hematologic cancer	2.86e-05	0.000117	CcSEcCtD
Terbinafine—Ill-defined disorder—Methotrexate—hematologic cancer	2.85e-05	0.000117	CcSEcCtD
Terbinafine—Tinnitus—Doxorubicin—hematologic cancer	2.85e-05	0.000117	CcSEcCtD
Terbinafine—Anaemia—Methotrexate—hematologic cancer	2.84e-05	0.000116	CcSEcCtD
Terbinafine—Feeling abnormal—Betamethasone—hematologic cancer	2.84e-05	0.000116	CcSEcCtD
Terbinafine—Feeling abnormal—Dexamethasone—hematologic cancer	2.84e-05	0.000116	CcSEcCtD
Terbinafine—Flatulence—Epirubicin—hematologic cancer	2.84e-05	0.000116	CcSEcCtD
Terbinafine—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.82e-05	0.000116	CcSEcCtD
Terbinafine—Gastrointestinal pain—Betamethasone—hematologic cancer	2.82e-05	0.000116	CcSEcCtD
Terbinafine—Dysgeusia—Epirubicin—hematologic cancer	2.82e-05	0.000115	CcSEcCtD
Terbinafine—Hypersensitivity—Triamcinolone—hematologic cancer	2.8e-05	0.000115	CcSEcCtD
Terbinafine—Angiopathy—Doxorubicin—hematologic cancer	2.77e-05	0.000114	CcSEcCtD
Terbinafine—Malaise—Methotrexate—hematologic cancer	2.77e-05	0.000114	CcSEcCtD
Terbinafine—Dizziness—Etoposide—hematologic cancer	2.77e-05	0.000114	CcSEcCtD
Terbinafine—Muscle spasms—Epirubicin—hematologic cancer	2.77e-05	0.000113	CcSEcCtD
Terbinafine—Immune system disorder—Doxorubicin—hematologic cancer	2.76e-05	0.000113	CcSEcCtD
Terbinafine—Vertigo—Methotrexate—hematologic cancer	2.76e-05	0.000113	CcSEcCtD
Terbinafine—Urticaria—Dexamethasone—hematologic cancer	2.74e-05	0.000112	CcSEcCtD
Terbinafine—Urticaria—Betamethasone—hematologic cancer	2.74e-05	0.000112	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.74e-05	0.000112	CcSEcCtD
Terbinafine—Dizziness—Prednisolone—hematologic cancer	2.73e-05	0.000112	CcSEcCtD
Terbinafine—Asthenia—Triamcinolone—hematologic cancer	2.73e-05	0.000112	CcSEcCtD
Terbinafine—Body temperature increased—Dexamethasone—hematologic cancer	2.73e-05	0.000112	CcSEcCtD
Terbinafine—Body temperature increased—Betamethasone—hematologic cancer	2.73e-05	0.000112	CcSEcCtD
Terbinafine—Abdominal pain—Dexamethasone—hematologic cancer	2.73e-05	0.000112	CcSEcCtD
Terbinafine—Abdominal pain—Betamethasone—hematologic cancer	2.73e-05	0.000112	CcSEcCtD
Terbinafine—Nausea—Cisplatin—hematologic cancer	2.72e-05	0.000111	CcSEcCtD
Terbinafine—Vision blurred—Epirubicin—hematologic cancer	2.71e-05	0.000111	CcSEcCtD
Terbinafine—Alopecia—Doxorubicin—hematologic cancer	2.7e-05	0.000111	CcSEcCtD
Terbinafine—Paraesthesia—Prednisone—hematologic cancer	2.7e-05	0.00011	CcSEcCtD
Terbinafine—Pruritus—Triamcinolone—hematologic cancer	2.69e-05	0.00011	CcSEcCtD
Terbinafine—Cough—Methotrexate—hematologic cancer	2.68e-05	0.00011	CcSEcCtD
Terbinafine—Mental disorder—Doxorubicin—hematologic cancer	2.68e-05	0.00011	CcSEcCtD
Terbinafine—Ill-defined disorder—Epirubicin—hematologic cancer	2.67e-05	0.000109	CcSEcCtD
Terbinafine—Vomiting—Etoposide—hematologic cancer	2.66e-05	0.000109	CcSEcCtD
Terbinafine—Erythema—Doxorubicin—hematologic cancer	2.66e-05	0.000109	CcSEcCtD
Terbinafine—Anaemia—Epirubicin—hematologic cancer	2.66e-05	0.000109	CcSEcCtD
Terbinafine—Dyspepsia—Prednisone—hematologic cancer	2.64e-05	0.000108	CcSEcCtD
Terbinafine—Rash—Etoposide—hematologic cancer	2.64e-05	0.000108	CcSEcCtD
Terbinafine—Dermatitis—Etoposide—hematologic cancer	2.64e-05	0.000108	CcSEcCtD
Terbinafine—Headache—Etoposide—hematologic cancer	2.62e-05	0.000108	CcSEcCtD
Terbinafine—Flatulence—Doxorubicin—hematologic cancer	2.62e-05	0.000107	CcSEcCtD
Terbinafine—Chest pain—Methotrexate—hematologic cancer	2.62e-05	0.000107	CcSEcCtD
Terbinafine—Arthralgia—Methotrexate—hematologic cancer	2.62e-05	0.000107	CcSEcCtD
Terbinafine—Myalgia—Methotrexate—hematologic cancer	2.62e-05	0.000107	CcSEcCtD
Terbinafine—Decreased appetite—Prednisone—hematologic cancer	2.61e-05	0.000107	CcSEcCtD
Terbinafine—Dysgeusia—Doxorubicin—hematologic cancer	2.61e-05	0.000107	CcSEcCtD
Terbinafine—Rash—Prednisolone—hematologic cancer	2.61e-05	0.000107	CcSEcCtD
Terbinafine—Dermatitis—Prednisolone—hematologic cancer	2.6e-05	0.000107	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.6e-05	0.000107	CcSEcCtD
Terbinafine—Malaise—Epirubicin—hematologic cancer	2.59e-05	0.000106	CcSEcCtD
Terbinafine—Fatigue—Prednisone—hematologic cancer	2.59e-05	0.000106	CcSEcCtD
Terbinafine—Headache—Prednisolone—hematologic cancer	2.59e-05	0.000106	CcSEcCtD
Terbinafine—Discomfort—Methotrexate—hematologic cancer	2.59e-05	0.000106	CcSEcCtD
Terbinafine—Vertigo—Epirubicin—hematologic cancer	2.59e-05	0.000106	CcSEcCtD
Terbinafine—Muscle spasms—Doxorubicin—hematologic cancer	2.56e-05	0.000105	CcSEcCtD
Terbinafine—Confusional state—Methotrexate—hematologic cancer	2.53e-05	0.000104	CcSEcCtD
Terbinafine—Dizziness—Triamcinolone—hematologic cancer	2.51e-05	0.000103	CcSEcCtD
Terbinafine—Cough—Epirubicin—hematologic cancer	2.51e-05	0.000103	CcSEcCtD
Terbinafine—Anaphylactic shock—Methotrexate—hematologic cancer	2.51e-05	0.000103	CcSEcCtD
Terbinafine—Vision blurred—Doxorubicin—hematologic cancer	2.51e-05	0.000103	CcSEcCtD
Terbinafine—Infection—Methotrexate—hematologic cancer	2.49e-05	0.000102	CcSEcCtD
Terbinafine—Nausea—Etoposide—hematologic cancer	2.49e-05	0.000102	CcSEcCtD
Terbinafine—Feeling abnormal—Prednisone—hematologic cancer	2.47e-05	0.000101	CcSEcCtD
Terbinafine—Asthenia—Dexamethasone—hematologic cancer	2.47e-05	0.000101	CcSEcCtD
Terbinafine—Asthenia—Betamethasone—hematologic cancer	2.47e-05	0.000101	CcSEcCtD
Terbinafine—Ill-defined disorder—Doxorubicin—hematologic cancer	2.47e-05	0.000101	CcSEcCtD
Terbinafine—Nervous system disorder—Methotrexate—hematologic cancer	2.46e-05	0.000101	CcSEcCtD
Terbinafine—Anaemia—Doxorubicin—hematologic cancer	2.46e-05	0.000101	CcSEcCtD
Terbinafine—Thrombocytopenia—Methotrexate—hematologic cancer	2.46e-05	0.000101	CcSEcCtD
Terbinafine—Gastrointestinal pain—Prednisone—hematologic cancer	2.46e-05	0.000101	CcSEcCtD
Terbinafine—Nausea—Prednisolone—hematologic cancer	2.45e-05	0.000101	CcSEcCtD
Terbinafine—Chest pain—Epirubicin—hematologic cancer	2.45e-05	0.0001	CcSEcCtD
Terbinafine—Arthralgia—Epirubicin—hematologic cancer	2.45e-05	0.0001	CcSEcCtD
Terbinafine—Myalgia—Epirubicin—hematologic cancer	2.45e-05	0.0001	CcSEcCtD
Terbinafine—Anxiety—Epirubicin—hematologic cancer	2.44e-05	0.0001	CcSEcCtD
Terbinafine—Pruritus—Dexamethasone—hematologic cancer	2.44e-05	9.99e-05	CcSEcCtD
Terbinafine—Pruritus—Betamethasone—hematologic cancer	2.44e-05	9.99e-05	CcSEcCtD
Terbinafine—Skin disorder—Methotrexate—hematologic cancer	2.44e-05	9.99e-05	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.43e-05	9.97e-05	CcSEcCtD
Terbinafine—Discomfort—Epirubicin—hematologic cancer	2.42e-05	9.92e-05	CcSEcCtD
Terbinafine—Vomiting—Triamcinolone—hematologic cancer	2.42e-05	9.9e-05	CcSEcCtD
Terbinafine—Malaise—Doxorubicin—hematologic cancer	2.4e-05	9.84e-05	CcSEcCtD
Terbinafine—Rash—Triamcinolone—hematologic cancer	2.4e-05	9.82e-05	CcSEcCtD
Terbinafine—Dry mouth—Epirubicin—hematologic cancer	2.4e-05	9.82e-05	CcSEcCtD
Terbinafine—Dermatitis—Triamcinolone—hematologic cancer	2.39e-05	9.81e-05	CcSEcCtD
Terbinafine—Vertigo—Doxorubicin—hematologic cancer	2.39e-05	9.8e-05	CcSEcCtD
Terbinafine—Anorexia—Methotrexate—hematologic cancer	2.39e-05	9.8e-05	CcSEcCtD
Terbinafine—Urticaria—Prednisone—hematologic cancer	2.39e-05	9.77e-05	CcSEcCtD
Terbinafine—Headache—Triamcinolone—hematologic cancer	2.38e-05	9.75e-05	CcSEcCtD
Terbinafine—Body temperature increased—Prednisone—hematologic cancer	2.37e-05	9.73e-05	CcSEcCtD
Terbinafine—Abdominal pain—Prednisone—hematologic cancer	2.37e-05	9.73e-05	CcSEcCtD
Terbinafine—Confusional state—Epirubicin—hematologic cancer	2.37e-05	9.7e-05	CcSEcCtD
Terbinafine—Diarrhoea—Betamethasone—hematologic cancer	2.36e-05	9.67e-05	CcSEcCtD
Terbinafine—Diarrhoea—Dexamethasone—hematologic cancer	2.36e-05	9.67e-05	CcSEcCtD
Terbinafine—Anaphylactic shock—Epirubicin—hematologic cancer	2.35e-05	9.62e-05	CcSEcCtD
Terbinafine—Infection—Epirubicin—hematologic cancer	2.33e-05	9.56e-05	CcSEcCtD
Terbinafine—Cough—Doxorubicin—hematologic cancer	2.32e-05	9.52e-05	CcSEcCtD
Terbinafine—Nervous system disorder—Epirubicin—hematologic cancer	2.3e-05	9.44e-05	CcSEcCtD
Terbinafine—Thrombocytopenia—Epirubicin—hematologic cancer	2.3e-05	9.42e-05	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.29e-05	9.37e-05	CcSEcCtD
Terbinafine—Skin disorder—Epirubicin—hematologic cancer	2.28e-05	9.35e-05	CcSEcCtD
Terbinafine—Dizziness—Betamethasone—hematologic cancer	2.28e-05	9.34e-05	CcSEcCtD
Terbinafine—Dizziness—Dexamethasone—hematologic cancer	2.28e-05	9.34e-05	CcSEcCtD
Terbinafine—Arthralgia—Doxorubicin—hematologic cancer	2.27e-05	9.29e-05	CcSEcCtD
Terbinafine—Chest pain—Doxorubicin—hematologic cancer	2.27e-05	9.29e-05	CcSEcCtD
Terbinafine—Myalgia—Doxorubicin—hematologic cancer	2.27e-05	9.29e-05	CcSEcCtD
Terbinafine—Anxiety—Doxorubicin—hematologic cancer	2.26e-05	9.25e-05	CcSEcCtD
Terbinafine—Nausea—Triamcinolone—hematologic cancer	2.26e-05	9.25e-05	CcSEcCtD
Terbinafine—Paraesthesia—Methotrexate—hematologic cancer	2.25e-05	9.23e-05	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.25e-05	9.22e-05	CcSEcCtD
Terbinafine—Discomfort—Doxorubicin—hematologic cancer	2.24e-05	9.18e-05	CcSEcCtD
Terbinafine—Anorexia—Epirubicin—hematologic cancer	2.24e-05	9.17e-05	CcSEcCtD
Terbinafine—Dry mouth—Doxorubicin—hematologic cancer	2.22e-05	9.08e-05	CcSEcCtD
Terbinafine—Hypersensitivity—Prednisone—hematologic cancer	2.21e-05	9.06e-05	CcSEcCtD
Terbinafine—Dyspepsia—Methotrexate—hematologic cancer	2.21e-05	9.05e-05	CcSEcCtD
Terbinafine—Vomiting—Dexamethasone—hematologic cancer	2.19e-05	8.98e-05	CcSEcCtD
Terbinafine—Vomiting—Betamethasone—hematologic cancer	2.19e-05	8.98e-05	CcSEcCtD
Terbinafine—Confusional state—Doxorubicin—hematologic cancer	2.19e-05	8.98e-05	CcSEcCtD
Terbinafine—Decreased appetite—Methotrexate—hematologic cancer	2.18e-05	8.94e-05	CcSEcCtD
Terbinafine—Rash—Betamethasone—hematologic cancer	2.17e-05	8.91e-05	CcSEcCtD
Terbinafine—Rash—Dexamethasone—hematologic cancer	2.17e-05	8.91e-05	CcSEcCtD
Terbinafine—Anaphylactic shock—Doxorubicin—hematologic cancer	2.17e-05	8.9e-05	CcSEcCtD
Terbinafine—Dermatitis—Betamethasone—hematologic cancer	2.17e-05	8.9e-05	CcSEcCtD
Terbinafine—Dermatitis—Dexamethasone—hematologic cancer	2.17e-05	8.9e-05	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.17e-05	8.88e-05	CcSEcCtD
Terbinafine—Fatigue—Methotrexate—hematologic cancer	2.16e-05	8.86e-05	CcSEcCtD
Terbinafine—Headache—Dexamethasone—hematologic cancer	2.16e-05	8.85e-05	CcSEcCtD
Terbinafine—Headache—Betamethasone—hematologic cancer	2.16e-05	8.85e-05	CcSEcCtD
Terbinafine—Infection—Doxorubicin—hematologic cancer	2.16e-05	8.84e-05	CcSEcCtD
Terbinafine—Asthenia—Prednisone—hematologic cancer	2.15e-05	8.83e-05	CcSEcCtD
Terbinafine—Pain—Methotrexate—hematologic cancer	2.15e-05	8.79e-05	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.14e-05	8.77e-05	CcSEcCtD
Terbinafine—Nervous system disorder—Doxorubicin—hematologic cancer	2.13e-05	8.73e-05	CcSEcCtD
Terbinafine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.13e-05	8.72e-05	CcSEcCtD
Terbinafine—Pruritus—Prednisone—hematologic cancer	2.12e-05	8.7e-05	CcSEcCtD
Terbinafine—Skin disorder—Doxorubicin—hematologic cancer	2.11e-05	8.65e-05	CcSEcCtD
Terbinafine—Paraesthesia—Epirubicin—hematologic cancer	2.11e-05	8.64e-05	CcSEcCtD
Terbinafine—Anorexia—Doxorubicin—hematologic cancer	2.07e-05	8.49e-05	CcSEcCtD
Terbinafine—Feeling abnormal—Methotrexate—hematologic cancer	2.07e-05	8.47e-05	CcSEcCtD
Terbinafine—Dyspepsia—Epirubicin—hematologic cancer	2.07e-05	8.47e-05	CcSEcCtD
Terbinafine—Diarrhoea—Prednisone—hematologic cancer	2.05e-05	8.42e-05	CcSEcCtD
Terbinafine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.05e-05	8.41e-05	CcSEcCtD
Terbinafine—Nausea—Dexamethasone—hematologic cancer	2.05e-05	8.39e-05	CcSEcCtD
Terbinafine—Nausea—Betamethasone—hematologic cancer	2.05e-05	8.39e-05	CcSEcCtD
Terbinafine—Decreased appetite—Epirubicin—hematologic cancer	2.04e-05	8.36e-05	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.03e-05	8.31e-05	CcSEcCtD
Terbinafine—Fatigue—Epirubicin—hematologic cancer	2.02e-05	8.3e-05	CcSEcCtD
Terbinafine—Pain—Epirubicin—hematologic cancer	2.01e-05	8.23e-05	CcSEcCtD
Terbinafine—Urticaria—Methotrexate—hematologic cancer	1.99e-05	8.17e-05	CcSEcCtD
Terbinafine—Dizziness—Prednisone—hematologic cancer	1.99e-05	8.14e-05	CcSEcCtD
Terbinafine—Abdominal pain—Methotrexate—hematologic cancer	1.98e-05	8.13e-05	CcSEcCtD
Terbinafine—Body temperature increased—Methotrexate—hematologic cancer	1.98e-05	8.13e-05	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.98e-05	8.11e-05	CcSEcCtD
Terbinafine—Paraesthesia—Doxorubicin—hematologic cancer	1.95e-05	7.99e-05	CcSEcCtD
Terbinafine—Feeling abnormal—Epirubicin—hematologic cancer	1.94e-05	7.93e-05	CcSEcCtD
Terbinafine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.92e-05	7.87e-05	CcSEcCtD
Terbinafine—Dyspepsia—Doxorubicin—hematologic cancer	1.91e-05	7.84e-05	CcSEcCtD
Terbinafine—Vomiting—Prednisone—hematologic cancer	1.91e-05	7.82e-05	CcSEcCtD
Terbinafine—Rash—Prednisone—hematologic cancer	1.89e-05	7.76e-05	CcSEcCtD
Terbinafine—Dermatitis—Prednisone—hematologic cancer	1.89e-05	7.75e-05	CcSEcCtD
Terbinafine—Decreased appetite—Doxorubicin—hematologic cancer	1.89e-05	7.74e-05	CcSEcCtD
Terbinafine—Headache—Prednisone—hematologic cancer	1.88e-05	7.71e-05	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.88e-05	7.69e-05	CcSEcCtD
Terbinafine—Fatigue—Doxorubicin—hematologic cancer	1.87e-05	7.68e-05	CcSEcCtD
Terbinafine—Urticaria—Epirubicin—hematologic cancer	1.87e-05	7.64e-05	CcSEcCtD
Terbinafine—Pain—Doxorubicin—hematologic cancer	1.86e-05	7.61e-05	CcSEcCtD
Terbinafine—Abdominal pain—Epirubicin—hematologic cancer	1.86e-05	7.61e-05	CcSEcCtD
Terbinafine—Body temperature increased—Epirubicin—hematologic cancer	1.86e-05	7.61e-05	CcSEcCtD
Terbinafine—Hypersensitivity—Methotrexate—hematologic cancer	1.85e-05	7.57e-05	CcSEcCtD
Terbinafine—Asthenia—Methotrexate—hematologic cancer	1.8e-05	7.38e-05	CcSEcCtD
Terbinafine—Feeling abnormal—Doxorubicin—hematologic cancer	1.79e-05	7.34e-05	CcSEcCtD
Terbinafine—Nausea—Prednisone—hematologic cancer	1.78e-05	7.31e-05	CcSEcCtD
Terbinafine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.78e-05	7.28e-05	CcSEcCtD
Terbinafine—Pruritus—Methotrexate—hematologic cancer	1.78e-05	7.27e-05	CcSEcCtD
Terbinafine—Hypersensitivity—Epirubicin—hematologic cancer	1.73e-05	7.09e-05	CcSEcCtD
Terbinafine—Urticaria—Doxorubicin—hematologic cancer	1.73e-05	7.07e-05	CcSEcCtD
Terbinafine—Abdominal pain—Doxorubicin—hematologic cancer	1.72e-05	7.04e-05	CcSEcCtD
Terbinafine—Body temperature increased—Doxorubicin—hematologic cancer	1.72e-05	7.04e-05	CcSEcCtD
Terbinafine—Diarrhoea—Methotrexate—hematologic cancer	1.72e-05	7.03e-05	CcSEcCtD
Terbinafine—Asthenia—Epirubicin—hematologic cancer	1.68e-05	6.9e-05	CcSEcCtD
Terbinafine—Pruritus—Epirubicin—hematologic cancer	1.66e-05	6.81e-05	CcSEcCtD
Terbinafine—Dizziness—Methotrexate—hematologic cancer	1.66e-05	6.8e-05	CcSEcCtD
Terbinafine—Diarrhoea—Epirubicin—hematologic cancer	1.61e-05	6.58e-05	CcSEcCtD
Terbinafine—Hypersensitivity—Doxorubicin—hematologic cancer	1.6e-05	6.56e-05	CcSEcCtD
Terbinafine—Vomiting—Methotrexate—hematologic cancer	1.6e-05	6.54e-05	CcSEcCtD
Terbinafine—Rash—Methotrexate—hematologic cancer	1.58e-05	6.48e-05	CcSEcCtD
Terbinafine—Dermatitis—Methotrexate—hematologic cancer	1.58e-05	6.48e-05	CcSEcCtD
Terbinafine—Headache—Methotrexate—hematologic cancer	1.57e-05	6.44e-05	CcSEcCtD
Terbinafine—Asthenia—Doxorubicin—hematologic cancer	1.56e-05	6.39e-05	CcSEcCtD
Terbinafine—Dizziness—Epirubicin—hematologic cancer	1.55e-05	6.36e-05	CcSEcCtD
Terbinafine—Pruritus—Doxorubicin—hematologic cancer	1.54e-05	6.3e-05	CcSEcCtD
Terbinafine—Vomiting—Epirubicin—hematologic cancer	1.49e-05	6.12e-05	CcSEcCtD
Terbinafine—Nausea—Methotrexate—hematologic cancer	1.49e-05	6.11e-05	CcSEcCtD
Terbinafine—Diarrhoea—Doxorubicin—hematologic cancer	1.49e-05	6.09e-05	CcSEcCtD
Terbinafine—Rash—Epirubicin—hematologic cancer	1.48e-05	6.07e-05	CcSEcCtD
Terbinafine—Dermatitis—Epirubicin—hematologic cancer	1.48e-05	6.06e-05	CcSEcCtD
Terbinafine—Headache—Epirubicin—hematologic cancer	1.47e-05	6.03e-05	CcSEcCtD
Terbinafine—Dizziness—Doxorubicin—hematologic cancer	1.44e-05	5.89e-05	CcSEcCtD
Terbinafine—Nausea—Epirubicin—hematologic cancer	1.39e-05	5.72e-05	CcSEcCtD
Terbinafine—Vomiting—Doxorubicin—hematologic cancer	1.38e-05	5.66e-05	CcSEcCtD
Terbinafine—Rash—Doxorubicin—hematologic cancer	1.37e-05	5.61e-05	CcSEcCtD
Terbinafine—Dermatitis—Doxorubicin—hematologic cancer	1.37e-05	5.61e-05	CcSEcCtD
Terbinafine—Headache—Doxorubicin—hematologic cancer	1.36e-05	5.58e-05	CcSEcCtD
Terbinafine—Nausea—Doxorubicin—hematologic cancer	1.29e-05	5.29e-05	CcSEcCtD
Terbinafine—CYP2C19—Metabolism—ADCY7—hematologic cancer	6.26e-06	0.000109	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NCOA3—hematologic cancer	6.26e-06	0.000109	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—SLC22A1—hematologic cancer	6.23e-06	0.000108	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CRABP1—hematologic cancer	6.23e-06	0.000108	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NUP214—hematologic cancer	6.21e-06	0.000108	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NCOR2—hematologic cancer	6.18e-06	0.000107	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.15e-06	0.000107	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ALOX5—hematologic cancer	6.12e-06	0.000106	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—MTR—hematologic cancer	6.09e-06	0.000106	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ABCG2—hematologic cancer	6.09e-06	0.000106	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ALOX5—hematologic cancer	6.07e-06	0.000105	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.06e-06	0.000105	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.98e-06	0.000104	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ENO2—hematologic cancer	5.97e-06	0.000104	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NUP98—hematologic cancer	5.93e-06	0.000103	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.92e-06	0.000103	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—IDH1—hematologic cancer	5.89e-06	0.000102	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NUP98—hematologic cancer	5.88e-06	0.000102	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTO1—hematologic cancer	5.82e-06	0.000101	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—TXN—hematologic cancer	5.82e-06	0.000101	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ABCC3—hematologic cancer	5.82e-06	0.000101	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTT1—hematologic cancer	5.79e-06	0.0001	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ADCY7—hematologic cancer	5.76e-06	9.99e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NCOA3—hematologic cancer	5.76e-06	9.99e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.72e-06	9.92e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NUP214—hematologic cancer	5.72e-06	9.92e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ADCY7—hematologic cancer	5.71e-06	9.9e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NCOA3—hematologic cancer	5.71e-06	9.9e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.7e-06	9.89e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SPHK1—hematologic cancer	5.7e-06	9.88e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—FHL2—hematologic cancer	5.68e-06	9.86e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NUP214—hematologic cancer	5.67e-06	9.83e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—SDC1—hematologic cancer	5.66e-06	9.82e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—MTHFR—hematologic cancer	5.65e-06	9.81e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CG—hematologic cancer	5.64e-06	9.79e-05	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PTEN—hematologic cancer	5.64e-06	9.79e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.61e-06	9.73e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ABCG2—hematologic cancer	5.6e-06	9.72e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—MTR—hematologic cancer	5.6e-06	9.72e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—AGRN—hematologic cancer	5.57e-06	9.67e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—MTR—hematologic cancer	5.55e-06	9.63e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ABCG2—hematologic cancer	5.55e-06	9.63e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ENO2—hematologic cancer	5.49e-06	9.53e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	5.47e-06	9.49e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ENO2—hematologic cancer	5.44e-06	9.45e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.41e-06	9.38e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CD44—hematologic cancer	5.39e-06	9.35e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—NQO1—hematologic cancer	5.39e-06	9.35e-05	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—EP300—hematologic cancer	5.38e-06	9.33e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.34e-06	9.26e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTT1—hematologic cancer	5.33e-06	9.24e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	5.32e-06	9.23e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CRABP1—hematologic cancer	5.32e-06	9.23e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—IDH2—hematologic cancer	5.28e-06	9.16e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HMMR—hematologic cancer	5.28e-06	9.16e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTT1—hematologic cancer	5.28e-06	9.16e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.28e-06	9.16e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CREBBP—hematologic cancer	5.23e-06	9.08e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—SDC1—hematologic cancer	5.21e-06	9.03e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.2e-06	9.02e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ALOX5—hematologic cancer	5.19e-06	9e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—SDC1—hematologic cancer	5.16e-06	8.95e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.11e-06	8.86e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYCS—hematologic cancer	5.1e-06	8.85e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	5.07e-06	8.8e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NUP98—hematologic cancer	5.02e-06	8.72e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.98e-06	8.64e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.97e-06	8.62e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CD—hematologic cancer	4.96e-06	8.61e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.93e-06	8.55e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—ALB—hematologic cancer	4.9e-06	8.5e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.88e-06	8.46e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.88e-06	8.46e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.87e-06	8.44e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NUP214—hematologic cancer	4.84e-06	8.4e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CA9—hematologic cancer	4.83e-06	8.38e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ACP5—hematologic cancer	4.83e-06	8.38e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CD44—hematologic cancer	4.81e-06	8.35e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NQO1—hematologic cancer	4.81e-06	8.35e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.79e-06	8.31e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.77e-06	8.27e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CG—hematologic cancer	4.75e-06	8.24e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—MTR—hematologic cancer	4.74e-06	8.23e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.74e-06	8.23e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.71e-06	8.18e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3R1—hematologic cancer	4.69e-06	8.13e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.66e-06	8.08e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ENO2—hematologic cancer	4.65e-06	8.07e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.56e-06	7.92e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYCS—hematologic cancer	4.55e-06	7.9e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—IDH1—hematologic cancer	4.54e-06	7.88e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	4.53e-06	7.85e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTT1—hematologic cancer	4.51e-06	7.83e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTP1—hematologic cancer	4.5e-06	7.8e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.49e-06	7.79e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—TXN—hematologic cancer	4.49e-06	7.79e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.49e-06	7.79e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.44e-06	7.71e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CD44—hematologic cancer	4.43e-06	7.68e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NQO1—hematologic cancer	4.43e-06	7.68e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SDC1—hematologic cancer	4.41e-06	7.65e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CREBBP—hematologic cancer	4.4e-06	7.64e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.4e-06	7.63e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CD44—hematologic cancer	4.39e-06	7.61e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NQO1—hematologic cancer	4.39e-06	7.61e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.35e-06	7.55e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CB—hematologic cancer	4.32e-06	7.5e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.3e-06	7.46e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ABCB1—hematologic cancer	4.26e-06	7.39e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.22e-06	7.33e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.21e-06	7.31e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYCS—hematologic cancer	4.19e-06	7.27e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CD—hematologic cancer	4.18e-06	7.25e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	4.16e-06	7.22e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.16e-06	7.22e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYCS—hematologic cancer	4.15e-06	7.2e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTM1—hematologic cancer	4.13e-06	7.17e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—NCOR1—hematologic cancer	4.13e-06	7.17e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.13e-06	7.16e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—ALB—hematologic cancer	4.12e-06	7.15e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.11e-06	7.13e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.11e-06	7.13e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.07e-06	7.07e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTP1—hematologic cancer	4.01e-06	6.96e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ALOX5—hematologic cancer	4e-06	6.94e-05	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PIK3CA—hematologic cancer	3.98e-06	6.9e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.98e-06	6.9e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3R1—hematologic cancer	3.94e-06	6.84e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.88e-06	6.74e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NUP98—hematologic cancer	3.88e-06	6.73e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.8e-06	6.59e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.76e-06	6.53e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.76e-06	6.53e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CD44—hematologic cancer	3.75e-06	6.51e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NQO1—hematologic cancer	3.75e-06	6.51e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NUP214—hematologic cancer	3.74e-06	6.48e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PTEN—hematologic cancer	3.74e-06	6.48e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.71e-06	6.44e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.69e-06	6.41e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTM1—hematologic cancer	3.69e-06	6.4e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NCOR1—hematologic cancer	3.69e-06	6.4e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.67e-06	6.37e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—MTR—hematologic cancer	3.66e-06	6.35e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.66e-06	6.35e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.66e-06	6.35e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.65e-06	6.34e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CB—hematologic cancer	3.64e-06	6.32e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ENO2—hematologic cancer	3.59e-06	6.23e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—EP300—hematologic cancer	3.56e-06	6.18e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYCS—hematologic cancer	3.55e-06	6.16e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.54e-06	6.14e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.53e-06	6.12e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.49e-06	6.06e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.48e-06	6.04e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.46e-06	6.01e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SDC1—hematologic cancer	3.4e-06	5.91e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.39e-06	5.89e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.39e-06	5.89e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.36e-06	5.84e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.36e-06	5.84e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.26e-06	5.66e-05	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—AKT1—hematologic cancer	3.25e-06	5.64e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.22e-06	5.58e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.17e-06	5.5e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PTEN—hematologic cancer	3.15e-06	5.46e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.13e-06	5.43e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.07e-06	5.32e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.03e-06	5.25e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—EP300—hematologic cancer	3e-06	5.2e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—MTHFR—hematologic cancer	3e-06	5.2e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.97e-06	5.16e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.96e-06	5.14e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NQO1—hematologic cancer	2.89e-06	5.02e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CD44—hematologic cancer	2.89e-06	5.02e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.87e-06	4.99e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.87e-06	4.99e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.87e-06	4.98e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.85e-06	4.94e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.74e-06	4.75e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYCS—hematologic cancer	2.74e-06	4.75e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.72e-06	4.72e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.7e-06	4.68e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ALB—hematologic cancer	2.66e-06	4.62e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CA—hematologic cancer	2.64e-06	4.57e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.62e-06	4.54e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.55e-06	4.42e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.54e-06	4.41e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.54e-06	4.41e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.52e-06	4.37e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.5e-06	4.33e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.41e-06	4.19e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.41e-06	4.18e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ALB—hematologic cancer	2.38e-06	4.12e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.35e-06	4.08e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.34e-06	4.05e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.32e-06	4.02e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.29e-06	3.96e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.27e-06	3.94e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.24e-06	3.88e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CA—hematologic cancer	2.22e-06	3.85e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.22e-06	3.85e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.22e-06	3.85e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.21e-06	3.84e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.2e-06	3.81e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ALB—hematologic cancer	2.19e-06	3.79e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ALB—hematologic cancer	2.17e-06	3.76e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—AKT1—hematologic cancer	2.15e-06	3.74e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.13e-06	3.7e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.1e-06	3.64e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.09e-06	3.63e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.07e-06	3.6e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PTEN—hematologic cancer	2.03e-06	3.53e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.98e-06	3.43e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.96e-06	3.4e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—EP300—hematologic cancer	1.94e-06	3.36e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.93e-06	3.35e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.91e-06	3.32e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.88e-06	3.25e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ALB—hematologic cancer	1.85e-06	3.21e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PTEN—hematologic cancer	1.81e-06	3.15e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—AKT1—hematologic cancer	1.81e-06	3.15e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.77e-06	3.07e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—EP300—hematologic cancer	1.73e-06	3e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.67e-06	2.89e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.65e-06	2.87e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.65e-06	2.86e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.64e-06	2.84e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—EP300—hematologic cancer	1.59e-06	2.76e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—EP300—hematologic cancer	1.58e-06	2.74e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.53e-06	2.65e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.45e-06	2.51e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.43e-06	2.49e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ALB—hematologic cancer	1.43e-06	2.48e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.41e-06	2.45e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.37e-06	2.37e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—EP300—hematologic cancer	1.35e-06	2.34e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.28e-06	2.22e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.26e-06	2.19e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.18e-06	2.04e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—AKT1—hematologic cancer	1.17e-06	2.03e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.17e-06	2.02e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.09e-06	1.89e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—AKT1—hematologic cancer	1.05e-06	1.81e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—EP300—hematologic cancer	1.04e-06	1.8e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	9.97e-07	1.73e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—AKT1—hematologic cancer	9.61e-07	1.67e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—AKT1—hematologic cancer	9.53e-07	1.65e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—AKT1—hematologic cancer	8.14e-07	1.41e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.69e-07	1.33e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—AKT1—hematologic cancer	6.29e-07	1.09e-05	CbGpPWpGaD
